By Adria Calatayud Roche Holding said Johannes Clevers, head of pharmaceutical research and early development, will retire from the company after three years in the role. Clevers, who was also ...

My PhD research is in the area of cancer immunotherapy. I worked in the oncology unit during my clinical rotation at the University of Nigeria Teaching Hospital (UNTH) as a pharmacy student. There ...

The National Institute for Pharmaceutical Research and Development (NIPRD) has announced the imminent commencement of the €18 million European Union ...

Romanian pharmaceutical company Antibiotice (BVB: ATB) plans to invest RON 376 million (approximately EUR 70 million) in a new research and development center focused on the production of critical ...